[vc_row pix_particles_check=""][vc_column][vc_wp_text]

The CBD Supply Chain

The benefits of CBD are understood and accepted by a broad range of consumers, clinicians, companies, and countries. While CBD as a medicine or food ingredient was once viewed with suspicion, it is now much more widely embraced.  Frankly, it's about time! *applause* Unfortunately, the rise in popularity brings with it ambiguous product quality (at best) or atrocious product standards (at worst). We definitely won't be applauding that.

CBD – A Consumer Health Revolution Amidst Regulatory Ambiguity CBD (cannabidiol), one of many cannabinoids derived from the plant Cannabis sativa L. (cannabis) has gained enormous popularity over the last decade. While positive consumer perception of CBD continues to rise around the world, research suggests that...

CBD - Transparency & Regulation for Consumer Safety CBD (cannabidiol), one of many cannabinoids derived from the plant Cannabis sativa L. (cannabis), has gained great popularity among consumers in recent years. The exponential growth of CBD in all consumer product categories might be taken to suggest...

[vc_row pix_particles_check=""][vc_column][vc_column_text]

Consumer Health – An Ever-Expanding Market

The global consumer health market, which includes key categories of over-the-counter products such as vitamins and dietary supplements, is valued at over $250 billion USD.1 Fueled by demand from health-focused consumers, an aging population, and growing wealth in emerging markets, the future growth of the multi-billion dollar global consumer health industry is expected to continue unabated through the coming decades. The main challenge currently facing the consumer health industry is to successfully determine which ideas to support through scale-up to shepherd into the market.

To explain what exactly it means to have Good Manufacturing Practices (GMP) is to ensure the consistent quality and safety of products by focusing on five key elements, which are often referred to as the 5 P's of GMP—people, premises, processes, products and procedures. GMP describes the minimum standard that a medicines manufacturer must meet in their production processes. The European Medicines Agency (EMA) coordinates inspections to verify compliance with these standards and plays a key role in harmonizing GMP activities at European Union (EU) level.